CA2872248A1 - Manufacturing and packaging room temperature stable dronabinol capsules - Google Patents

Manufacturing and packaging room temperature stable dronabinol capsules Download PDF

Info

Publication number
CA2872248A1
CA2872248A1 CA2872248A CA2872248A CA2872248A1 CA 2872248 A1 CA2872248 A1 CA 2872248A1 CA 2872248 A CA2872248 A CA 2872248A CA 2872248 A CA2872248 A CA 2872248A CA 2872248 A1 CA2872248 A1 CA 2872248A1
Authority
CA
Canada
Prior art keywords
cannabinoid
packaging
capsules
oil
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2872248A
Other languages
English (en)
French (fr)
Inventor
Venkat GOSKONDA
Ashok Chavan
Kiran AMANCHA
Scott CRISMAN
Crystal LOPEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insys Pharma Inc
Original Assignee
Insys Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insys Therapeutics Inc filed Critical Insys Therapeutics Inc
Publication of CA2872248A1 publication Critical patent/CA2872248A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
CA2872248A 2012-05-07 2013-03-27 Manufacturing and packaging room temperature stable dronabinol capsules Abandoned CA2872248A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261643713P 2012-05-07 2012-05-07
US61/643,713 2012-05-07
PCT/US2013/033991 WO2013169406A1 (en) 2012-05-07 2013-03-27 Manufacturing and packaging room temperature stable dronabinol capsules

Publications (1)

Publication Number Publication Date
CA2872248A1 true CA2872248A1 (en) 2013-11-14

Family

ID=49513014

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2872248A Abandoned CA2872248A1 (en) 2012-05-07 2013-03-27 Manufacturing and packaging room temperature stable dronabinol capsules

Country Status (5)

Country Link
US (1) US8741341B2 (enExample)
EP (1) EP2846782A4 (enExample)
JP (1) JP2015518494A (enExample)
CA (1) CA2872248A1 (enExample)
WO (1) WO2013169406A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
ES2835720T3 (es) * 2014-06-11 2021-06-23 Poviva Corp Composiciones de alimentos y bebidas infusionadas con agentes activos lipófilos y métodos de uso de las mismas
EP3164141B1 (en) 2014-06-11 2020-11-11 Poviva Corp. Food and beverage compositions infused with lipophilic active agents and methods of use thereof
CA3176674A1 (en) 2015-05-18 2016-11-24 5071, Inc. Homogenous cannabis compositions and methods of making the same
ES2938560T3 (es) * 2015-05-28 2023-04-12 Radius Pharmaceuticals Inc Formulaciones de cannabinoides estables
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3737371A4 (en) * 2018-01-10 2021-10-06 Benuvia Therapeutics, LLC DRONABINOL STABILIZATION PROCESSES
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
US20230001128A1 (en) * 2019-11-25 2023-01-05 Gary Stephen Shuster Aerosolization systems, methods, and apparatuses
WO2021216475A1 (en) 2020-04-20 2021-10-28 Poviva Corp. Compositions and methods for enhanced delivery of antiviral agents
US20230390209A1 (en) * 2020-10-23 2023-12-07 Fuji Capsule Co., Ltd. Cannabidiol-containing seamless soft capsule
EP4591855A1 (en) 2024-01-23 2025-07-30 Echo Pharmaceuticals B.V. Stable dronabinol compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4917671U (enExample) * 1972-05-17 1974-02-14
JPS60183374A (ja) * 1984-02-24 1985-09-18 大日本印刷株式会社 脱酸素密封包装物の製造法
HRP20040816A2 (en) * 2002-04-03 2005-06-30 Solvay Pharmaceuticals B.V. Stabilized natural cannabinoid formulation
PL215220B1 (pl) * 2002-08-14 2013-11-29 Gw Pharma Ltd Ciekly preparat farmaceutyczny
JP4341835B2 (ja) * 2004-04-13 2009-10-14 日本化薬株式会社 カプセル剤の保存容器並びに保存方法
US7633097B2 (en) 2004-09-23 2009-12-15 Philips Lumileds Lighting Company, Llc Growth of III-nitride light emitting devices on textured substrates
EA200701246A1 (ru) * 2004-12-09 2008-06-30 Инсис Терапьютикс, Инк. Стабильные при комнатной температуре составы дронабинола
JP5053544B2 (ja) * 2004-12-28 2012-10-17 株式会社カネカ 還元型補酵素ｑ１０の保存方法
WO2007109824A1 (en) * 2006-03-24 2007-10-04 Ian Simon Tracton Stable packaged dosage form and process therefor
US8039509B2 (en) * 2006-11-10 2011-10-18 Johnson Matthey Public Limited Company Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
US8222292B2 (en) 2007-08-06 2012-07-17 Insys Therapeutics, Inc. Liquid cannabinoid formulations
CA2698752A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
US20120043242A1 (en) * 2010-08-19 2012-02-23 Andrew David Hospodor Medicinal cannabis fatty foodstuff
EP2621509A4 (en) 2010-09-15 2016-08-03 Synergy Pharmaceuticals Inc FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHOD OF USE

Also Published As

Publication number Publication date
JP2015518494A (ja) 2015-07-02
EP2846782A4 (en) 2016-01-20
US8741341B2 (en) 2014-06-03
EP2846782A1 (en) 2015-03-18
WO2013169406A1 (en) 2013-11-14
US20130296415A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
US8741341B2 (en) Manufacturing and packaging room temperature stable dronabinol capsules
US20240226032A9 (en) Pharmaceutical composition comprising a cannabinoid
JP5943915B2 (ja) リファキシミンの製剤およびその使用
CA2666512C (en) Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
CN102470103B (zh) 用作丙型肝炎病毒蛋白酶抑制剂的药物组合物
US9504656B2 (en) Pharmaceutical compositions for poorly soluble active ingredients
ES2560669T3 (es) Composiciones de tiacumicinas estables
MX2007007038A (es) Formulacion de dronabinol en temperatura ambiente.
BRPI0720248A2 (pt) Artigo de fabricação de prasugrel
WO2018112119A1 (en) Non-aqueous delta9-tetrahydrocannabinol oral liquid formulations
US20040115257A1 (en) Retinoid agent capsule system
WO2021163023A1 (en) Stable formulations of dronabinol
JP2012072169A (ja) Ｅｄ−７１製剤
EP2259801B1 (en) Stable pharmaceutical compositions of carvedilol
CA3232209A1 (en) Compositions and methods for treating patients with dementia due to alzheimer's disease with a combination of thc and melatonin
TW201340969A (zh) 有效ｈｃｖ抑制劑之穩定醫藥調配物
US20190209517A1 (en) Methods of stabilizing dronabinol
JP7118412B2 (ja) バンコマイシン懸濁液充填カプセル製剤
RU2279873C2 (ru) Пероральная фармацевтическая композиция для мягких капсул, содержащая винорелбин, и способ лечения
HK1161081A (en) Oral dosage forms of bendamustine
EP2890369A1 (en) Pharmaceutical compositions comprising an active agent

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180327